Literature DB >> 17347473

Upregulation of macrophage endothelial lipase by toll-like receptors 4 and 3 modulates macrophage interleukin-10 and -12 production.

Xun Wang1, Weijun Jin, Daniel J Rader.   

Abstract

Limited data suggest that endothelial lipase (EL) is synthesized not only by endothelial cells but also by macrophages. Previous studies showed that proinflammatory cytokines upregulate EL in endothelial cells, but there are very few data regarding EL expression, regulation, and functional consequences in macrophages. In the present study, RAW cells and mouse peritoneal macrophages were treated with Toll-like receptor (TLR) ligands and EL expression and its consequences were assessed. We demonstrate that lipopolysaccharide, a TLR4 ligand; and polyinosinic:polycytidylic acid (poly I:C), a TLR3 ligand; but not lipoteichoic acid, a TLR2 ligand, upregulate macrophage EL expression both ex vivo and in vivo. In contrast, macrophage lipoprotein lipase expression is significantly repressed by lipopolysaccharide or poly I:C. Using C3HJ and TLR3 knockout mice, we further show that upregulation of macrophage EL expression by lipopolysaccharide or poly I:C is TLR4 or TLR3 dependent, respectively. Furthermore, we demonstrate that lipopolysaccharide induced interleukin (IL)-10 production was significantly reduced, whereas IL-12 production is significantly increased in J744 macrophages and mouse peritoneal macrophages overexpressing human EL. Conversely, significantly increased IL-10 and significantly decreased IL-12 expression were observed in mouse peritoneal macrophages isolated from EL knockout mice. Finally we show that the catalytic activity is required for EL to modulate the balance of macrophage IL-10 and IL-12 production. These results suggest that macrophage EL may play important roles in modulating the macrophage inflammatory response through local hydrolysis of HDL.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17347473     DOI: 10.1161/01.RES.0000263011.34709.c5

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  10 in total

1.  Targeted deletion of endothelial lipase increases HDL particles with anti-inflammatory properties both in vitro and in vivo.

Authors:  Tetsuya Hara; Tatsuro Ishida; Yoko Kojima; Hanayo Tanaka; Tomoyuki Yasuda; Masakazu Shinohara; Ryuji Toh; Ken-ichi Hirata
Journal:  J Lipid Res       Date:  2010-10-06       Impact factor: 5.922

2.  The role of HDL in innate immunity.

Authors:  Kenneth R Feingold; Carl Grunfeld
Journal:  J Lipid Res       Date:  2010-10-13       Impact factor: 5.922

3.  Impact of miR-140 Deficiency on Non-Alcoholic Fatty Liver Disease.

Authors:  Benjamin Wolfson; Pang-Kuo Lo; Yuan Yao; Linhao Li; Hongbing Wang; Qun Zhou
Journal:  Mol Nutr Food Res       Date:  2018-06-12       Impact factor: 5.914

Review 4.  The role of endothelial lipase in lipid metabolism, inflammation, and cancer.

Authors:  Justine E Yu; Shu-Yan Han; Benjamin Wolfson; Qun Zhou
Journal:  Histol Histopathol       Date:  2017-05-25       Impact factor: 2.303

5.  Co-expressed immune and metabolic genes in visceral and subcutaneous adipose tissue from severely obese individuals are associated with plasma HDL and glucose levels: a microarray study.

Authors:  Marcel G M Wolfs; Sander S Rensen; Elinda J Bruin-Van Dijk; Froukje J Verdam; Jan-Willem Greve; Bahram Sanjabi; Marcel Bruinenberg; Cisca Wijmenga; Timon W van Haeften; Wim A Buurman; Lude Franke; Marten H Hofker
Journal:  BMC Med Genomics       Date:  2010-08-05       Impact factor: 3.063

6.  Fatty acids regulate endothelial lipase and inflammatory markers in macrophages and in mouse aorta: a role for PPARγ.

Authors:  Un Ju Jung; Claudia Torrejon; Chuchun L Chang; Hiroko Hamai; Tilla S Worgall; Richard J Deckelbaum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-10-04       Impact factor: 8.311

7.  Measurement of the phospholipase activity of endothelial lipase in mouse plasma.

Authors:  Debapriya Basu; Xia Lei; Joby Josekutty; M Mahmood Hussain; Weijun Jin
Journal:  J Lipid Res       Date:  2012-10-26       Impact factor: 5.922

8.  LIPG signaling promotes tumor initiation and metastasis of human basal-like triple-negative breast cancer.

Authors:  Pang-Kuo Lo; Yuan Yao; Ji Shin Lee; Yongshu Zhang; Weiliang Huang; Maureen A Kane; Qun Zhou
Journal:  Elife       Date:  2018-01-19       Impact factor: 8.140

9.  Effects of a novel pharmacologic inhibitor of myeloperoxidase in a mouse atherosclerosis model.

Authors:  Cuiqing Liu; Rajagopal Desikan; Zhekang Ying; Liubov Gushchina; Thomas Kampfrath; Jeffrey Deiuliis; Aixia Wang; Xiaohua Xu; Jixin Zhong; Xiaoquan Rao; Qinghua Sun; Andrei Maiseyeu; Sampath Parthasarathy; Sanjay Rajagopalan
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

10.  Inflammatory mediator profiling reveals immune properties of chemotactic gradients and macrophage mediator production inhibition during thioglycollate elicited peritoneal inflammation.

Authors:  Derek Lam; Devon Harris; Zhenyu Qin
Journal:  Mediators Inflamm       Date:  2013-03-31       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.